The cellular components of the neuronal signaling pathways of Eph receptor tyrosine kinases are only beginning to be elucidated. Here we show that in vivo tyrosine phosphorylation sites of the Eph receptors EphA3, EphA4, and EphB2 in embryonic retina serve as binding sites for the Src-homology 2 (SH2) domain of Src kinase. Furthermore, tyrosine-phosphorylated EphB2 was detected in Src immunoprecipitates from transfected Cos cells, indicating that EphB2 and Src can physically associate. Interestingly, a form of Src with reduced electrophoretic mobility and increased tyrosine phosphorylation was detected in Cos cells expressing tyrosine-phosphorylated EphB2, suggesting a functional interaction between EphB2 and Src. Yeast two-hybrid analysis in conjunction with site-directed mutagenesis demonstrated that phosphorylated tyrosine 611 in the juxtamembrane region of EphB2 is crucial for the interaction with the SH2 domain of Src. In contrast, binding of the carboxy-terminal SH2 domain of phospholipase Cg was not abolished upon mutation of tyrosine 611 in EphB2. Phosphopeptide mapping of autophosphorylated full-length EphB2, and wild-type and tyrosine to phenylalanine mutants of the EphB2 cytoplasmic domain fused to LexA, showed tyrosine 611 in the sequence motif YEDP as a major site of autophosphorylation in EphB2. Our mutational analysis also indicated that tyrosines 605 and 611 are important for EphB2 kinase activity. We propose Src kinase as a downstream eector that mediates the neuron's response to Eph receptor activation.
Introduction
The Eph family is the largest known family of receptor tyrosine kinases (Sajjadi and Pasquale, 1993; van der Geer et al., 1994; Eph Nomenclature Committee, 1997) . The structural features of the Eph receptors, as well as their expression on navigating axons and distribution in the developing embryo, suggest that these molecules play a pivotal role in mediating signals that govern pattern formation in both the developing nervous system and non-neural tissues Tessier-Lavigne, 1995; . Structurally, in their extracellular portion the Eph receptors share homology with cell adhesion molecules, while their intracellular portion exhibits similarity to the cytoplasmic domains of growth factor receptors (van der Geer et al., 1994) .
A number of ligands that bind to the extracellular portion of the Eph receptors have been identi®ed, but, unlike diusible growth factors, these ligands are anchored on the surface of cells (reviewed by Pandey et al., 1995a) . Upon cell-cell contact, cells expressing a ligand are able to in¯uence the behavior of cells or growth cones bearing the cognate Eph receptor on their surface. Instructive, repulsive modes of interaction between Eph receptors and their ligands have been proposed to underlie the precise projection of retinal ganglion cells into the optic tectum during the chick visual pathway formation (Cheng et al., 1995; Drescher et al., 1995; Nakamoto et al., 1996; Monschau et al., 1997) , as well as the guidance of migratory neural crest cells and motor axons to the rostral halves of developing somites (Wang and Anderson, 1997) . Neural abnormalities that suggest defects in axon guidance have been observed upon inactivation by homologous recombination of several Eph receptor genes, including EphB2 Orioli et al., 1996; Park et al., 1997) .
Although gene targeting experiments and studies in the chicken embryo have allowed exciting insights in the function of Eph receptors and their ligands in establishing neuronal projections, the molecular mechanism underlying Eph receptor-mediated signaling remain largely unknown. The Eph receptors can be subdivided into two groups based on their speci®city for transmembrane or glycosyl phosphatidylinositolanchored ligands Eph Nomenclature Committee, 1997) . Since the receptors within each group exhibit similar ligand speci®city and often have partially overlapping distributions in embryonic tissues , it is possible that they may have redundant functions. It is therefore important to identify the signaling molecules that interact with the cytoplasmic domains of the Eph receptors in order to elucidate whether dierent receptors within the same subgroup have identical or unique signaling properties.
The binding of ligands to their cognate Eph receptors on apposing cell surfaces results in autophosphorylation of the Eph receptor on tyrosines in the intracellular domain (Bartley et al., 1994; Davis et al., 1994) . This has also been demonstrated for EphB2 (formerly designated Cek5, Nuk, or Sek-3) (Eph Nomenclature Committee, 1997) upon binding of its ligand ephrin-B1 (formerly Cek5-L or LERK2) (Shao et al., 1994; Holash et al., 1997) . Tyrosine phosphorylation of EphB2 is crucial for the recruitment of signaling molecules through specialized phosphotyrosine interaction domains, such as Src homology 2 (SH2) domains or phosphotyrosine binding (PTB) domains (Pawson and Schlessinger, 1993; Kavanaugh et al., 1995) . Some of the phosphotyrosine-binding eector molecules presumably mediate the rapid cytoskeletal alterations that accompany Eph receptor mediated neuronal growth cone turning or collapse (Meima et al., 1997a,b) .
Several known signaling molecules containing SH2 domains, such as Fyn, the regulatory subunit of phosphatidylinositol 3-kinase, SLAP (Src-like adaptor molecule), Grb2, Grb10 and most recently, the RasGTPase activating protein RasGAP have been shown to interact with certain Eph receptors (Pandey et al., , 1995b Ellis et al., 1996; Stein et al., 1996; Holland et al., 1997) . This report investigates Src kinases as possible mediators of EphB2 signaling. Several members of the Src family, including Src, Fyn and Yes, are highly expressed in the same places as EphB2, most notably developing neurons, where they are concentrated in axons and growth cones (Ingraham et al., 1992; Maness and Cox, 1992; Bixby and Jhabvala, 1993) . Src, based on its expression pattern, is the most likely among the Src family kinases to interact with activated EphB2 in vivo. In the chicken embryo, for example, both EphB2 and Src are highly concentrated in the molecular layer of the cerebellum and in the inner plexiform layer and nerve ®ber layer of the retina (Sorge et al., 1984; Fults et al., 1985) .
Autophosphorylated tyrosine 602 in the juxtamembrane region of the mouse EphA4 receptor (formerly Cek8 or Sek-1) has been shown to be critical for the association between a glutathione S-transferase (GST) fusion protein of EphA4 and Fyn (Ellis et al., 1996) . Our results demonstrate that autophosphorylation tyrosine 611 in the juxtamembrane region of chicken EphB2 is critical for the association of the Src SH2 domain. However, Src appeared as the preferential binding partner over Fyn and Yes when the binding of SH2 domains to in vivo phosphorylated EphB2 was measured. Phosphopeptide mapping studies revealed the presence of additional phosphorylation sites outside the justamembrane region of EphB2. Interestingly, mutation of tyrosine 605 and 611 to phenylalanine impaired kinase activity, indicating the potential importance of these residues in regulating EphB2 kinase activity.
Results

Src family kinases bind to tyrosine phosphorylated EphB2
To assess if the Eph receptor EphB2 contains docking sites for the SH2 domains of kinases of the Src family, we performed a ®lter binding assay using the entire cytoplasmic domain of EphB2 fused to glutathione Stransferase (GST-EphB2) as a probe. Immunoblotting with anti-phosphotyrosine antibodies demonstrated that the expression of GST-EphB2 in bacteria results in its ligand-independent autophosphorylation ( Figure  1a ). After puri®cation, the GST-EphB2 fusion protein retained catalytic activity and became autophosphorylated to a greater extent on sepharose beads in the presence of [g 32 P]ATP (Figure 1a ). The 32 P-labeled GST-EphB2 was used to probe for a protein interaction between EphB2 and the SH2 domains of chicken Src and chicken Yes, which were expressed as GST fusion proteins and immobilized on a ®lter. Both the Src and Yes SH2 domains, but not GST alone, bound GST-EphB2 in a dose dependent manner (Figure 1b ). This result suggests that the cytoplasmic domain of EphB2 contains autophosphorylation sites that mediate the direct binding of the SH2 domains of Src family kinases.
To verify that the interaction between EphB2 and the SH2 domain of Src also occurs under more physiological conditions, we transiently expressed fulllength EphB2 in B28 rat glioblastoma cells. Transfection of these cells with EphB2 in the expression plasmid pcDNA3 results in the expression of the receptor as the tyrosine phosphorylated, activated form and as the major tyrosine phosphorylated protein in the cells (Zisch et al., 1997) . The SH2 domain of Src fused to GST and immobilized on agarose was incubated with lysates of the EphB2-transfected cells. The proteins retained on the SH2 domain-agarose matrix were analysed by SDS ± PAGE and immunoblotting with anti-phosphotyrosine antibodies ( Figure 1c) . A protein doublet of about 120 K, characteristic of the EphB2 protein expressed in B28 transfectants, speci®cally bound to the Src SH2 domain but not to GST. To verify that the doublet was EphB2, the material bound to the Src SH2 domain was eluted and immunoprecipitated with anti-EphB2 antibodies or control antibodies. Immunoblotting with anti-phosphotyrosine antibodies detected EphB2 only in the immunoprecipitates obtained with anti-EphB2 antibodies ( Figure 1d ). This observation indicates that the SH2 domain of Src interacts with the tyrosine phosphorylated, full-length form of EphB2 expressed in eukaryotic cells.
Formation of complexes between full-length Src and activated EphB2 was examined in co-precipitation experiments using Cos cells transiently transfected with EphB2, Src, or both Src and EphB2 (Figure 2 ). Figure 2a shows the expression of Src and EphB2 and the overall levels of protein tyrosine phosphorylation in the transfected Cos cells. EphB2 and Src were both phosphorylated on tyrosine when transiently expressed in Cos cells (Figure 2a, lanes 6, 7, and 8) . Lysates of Cos cells were immunoprecipitated with anti-Src antibodies and the immunoprecipitates were subjected to SDS ± PAGE followed by immunoblotting with antiphosphotyrosine antibodies (Figure 2b ). EphB2 was detected in Src immunoprecipitates from Cos cells transfected with both EphB2 and Src (Figure 2b , lane 4), but not in control immunoprecipitates from Cos cells transfected only with Src ( Figure 2b , lane 3). EphB2 was also detected, albeit at lower levels, in immunoprecipitates of endogenous Src from Cos cells transfected only with EphB2 ( Figure 2b , lane 2). Coprecipitation of activated EphB2 and full-length Src shows that they are able to interact with each other when they are present in the same cells.
Interestingly, a form of Src with reduced electrophoretic mobility was detected in Cos cells that also contained activated EphB2 (Figure 2a , compare lanes 3 and 4). To examine whether the form of Src with reduced electrophoretic mobility exhibited dierential phosphorylation on tyrosine, we performed immunoprecipitations with anti-phosphotyrosine antibodies followed by immunoblotting with anti-Src antibodies ( Figure 2c , lanes 2 and 3) as well as immunoprecipitations with anti-Src antibodies followed by immunoblotting with anti-phosphotyrosine antibodies ( Figure  2c, lane 4) . These experiments demonstrated that the form of Src with reduced mobility is preferentially recognized by the anti-phosphotyrosine antibodies and that substantially higher amounts of this dierentially tyrosine-phosphorylated form of Src are present in EphB2-expressing cells. Thus, the presence of tyrosine phosphorylated EphB2 causes modi®cation(s) in Src that are re¯ected in its reduced electrophoretic mobility and increased phosphorylation on tyrosine, suggesting a functional link between EphB2 and Src.
To demonstrate that in vivo phosphorylation sites of EphB2 serve as binding sites for Src family kinases, we compared the interaction of the SH2 domains of Src, Yes, and Fyn with EphB2 from embryonic day 13 chicken retina, in which EphB2 is highly phosphorylated on tyrosine Zisch et al., 1997) . The SH2 domains were expressed in bacteria as GST-fusion proteins, puri®ed on glutathione-sepharose, and then incubated with membrane extracts of chicken retina. Proteins retained on the SH2 domain-sepharose were separated by SDS ± PAGE and analysed by immunoblotting with antibodies speci®c for EphB2 (Figure 3 ). EphB2 from retina bound preferentially to the immobilized SH2 domain of Src and to a lesser extent to the SH2 domain of Yes, but did not exhibit detectable binding to the SH2 domain of Fyn. Two other Eph receptors that are expressed in the chicken embryonic retina, EphA3 (formerly Cek4 or Mek4) and EphA4 (formerly Cek8 or Sek1, Soans et al., 1994; Cheng et al., 1995) , also preferentially bound to the SH2 domain of Src (Figure 3 ). Like EphB2, P-labeled GST-EphB2 was resolved by SDS ± PAGE and detected by autoradiography ( 32 P). (b) 32 P-labeled GST-EphB2 was incubated with the SH2 domains of Yes and Src expressed as GST fusion proteins, or GST alone, immobilized on a nitrocellulose ®lter at increasing concentrations (left to right). Bound 32 P-labeled GST-EphB2 was detected by autoradiography. (c) RIPA-lysates of B28 rat glioblastoma cells transfected with EphB2-pcDNA3 were incubated with Src-SH2 agarose (Oncogene Science) or GST-sepharose as a control. Bound material was eluted by boiling in SDS-containing buer. Aliquots of the eluates were separated by SDS ± PAGE and electrotransferred to PVDF membrane. Probing with antiphosphotyrosine antibodies detects a prominent doublet at 120 kD characteristic for EphB2 in B28 transfectants. (d) The presence of EphB2 in the eluates was veri®ed by immunoprecipitation with anti-EphB2 antibodies and probing with anti-phosphotyrosine antibodies. Preimmune rabbit IgG were used as a control for the immunoprecipitations. Sizes of molecular weight markers are indicated to the right EphA3 in addition bound to Yes but at lower levels. EphA3 was the only Eph receptor tested that bound at detectable levels to the SH2 domain of Fyn. Reprobing with anti-phosphotyrosine antibodies visualized the subsets of phosphoproteins that interacted with the dierent SH2 domains (Figure 3 ). Each SH2 domain bound a variety of tyrosine phosphorylated proteins from retina extracts, although Src appeared to bind the most tyrosine phosphorylated proteins.
The SH2 domain of Src binds to tyrosine 611 of EphB2
Examination of the cytoplasmic domain of EphB2 revealed that two tyrosines in the juxtamembrane region, tyrosine 605 and tyrosine 611 (Figure 4) , are located within a stretch of sequence that is highly conserved in the Eph family (Sajjadi and Pasquale, 1993; Fox et al., 1995) . The sequence motifs surrounding these tyrosines resemble previously identi®ed high anity Src family binding motifs, such as YEEI (Songyang et al., 1993) and YEDP (Ellis et al., 1996) . To evaluate the role of tyrosines 605 and 611 of EphB2 in Src binding, we used the yeast two-hybrid system (Fields and Song, 1989; Vojtek and Hollenberg, 1995) in conjunction with site-directed mutagenesis. The entire cytoplasmic domain of EphB2 (`bait' protein) was fused to the LexA DNA-binding domain in the yeast expression vector pBTM116 (LexA:EphB2). LexA:EphB2 mutants were also generated in which tyrosine residues 605 (LexA:EphB2 Y605F), 611 (LexA:EphB2 Y611F), or both (LexA:EphB2 Y605/ 611F) were mutated to phenylalanine. Expression levels of wild-type and mutant LexA:EphB2 fusion proteins were determined by probing yeast lysates with anti-EphB2 antibodies ( Figure 5a ). LexA:EphB2 wild-type and mutant fusion proteins of the expected molecular size of about 70 K were expressed at similar levels ( Figure  5a ). Partial proteolytic digestion products were also observed for the wild-type and the mutant LexA:EphB2 proteins. Immunoblotting with antiphosphotyrosine antibodies detected high levels of autophosphorylated wild-type LexA:EphB2 ( Figure  5b ). Autophosphorylation on tyrosine, however, appeared to be strongly impaired in the mutated LexA:EphB2 proteins as it was undetectable by immunoblotting. The ability of the mutants to autophosphorylate was, therefore, investigated further by using a more sensitive in vitro kinase assay with the immunoprecipitated LexA:EphB2 fusion proteins (Figure 5c, d) . Comparison of levels of autophosphorylation between wild-type an the mutated LexA:EphB2 proteins revealed reduced but still substantial levels of autophosphorylation of the mutated proteins. Notably, we observed autophosphorylation of LexA:EphB2 Y605/611F, indicating that additional tyrosines other than those mutated to phenylalanine represent autophosphorylation sites.
To con®rm the relevance of the autophosphorylation sites of the yeast LexA:EphB2 bait, phosphopeptide mapping was used to compare the patterns of autophosphorylation of wild-type LexA:EphB2 and full-length EphB2 from transfected 293 cells ( Figure 6 ). Immunoprecipitated LexA:EphB2 and full-length EphB2 were subjected to in vitro autophosphorylation with [g anti-EphB2
Figure 3 Src family kinases bind to EphB2, EphA3 and EphA4 from embryonic day 13 chicken retina. RIPA-extracts of embryonic day 13 chicken retina were incubated with the puri®ed GST-SH2 domains of Yes, Src, Fyn and GST bound to glutathione sepharose. Proteins bound to the sepharose beads were eluted in Laemmli-sample buer. Aliquots were probed by immunoblotting with antibodies speci®c for EphB2 (anti-EphB2-b-galactosidase) and EphA4. The ®lter probed with anti-EphA4 antibodies was then sequentially stripped and reprobed with antiEphA3 antibodies, anti-phosphotyrosine (anti-pY) antibodies, and anti-GST antibodies, as indicated. Immunodetection with anti-GST antibodies veri®ed that comparable amounts of GST fusion proteins were bound to the glutathione beads. Sizes of molecular weight markers are indicated to the right Figure 4 Sequence motifs in the juxtamembrane region of the EphB2 cytoplasmic domain are possible binding sites for SH2 domains. The cytoplasmic domain of EphB2 (Pasquale, 1991) comprises amino acids 575 to 995. All tyrosines in the EphB2 cytoplasmic domain are marked by vertical bars. Tyrosine 789 (marked by asterisk) is a conserved tyrosine that may represent an additional site of autophosphorylation (Hanks et al., 1988) . TM, transmembrane domain. The 16 amino acid insert found in a variant form of EphB2 (previously designated Cek5+) (Sajjadi and Pasquale, 1993 ) is indicated. The numbering of the positions of tyrosines 605 and 611 refers to the sequence of EphB2 followed by ascending chromatography, seven distinct phosphopeptides (a ± g) were detected for wild-type LexA:EphB2 (Figure 6b ). All the phosphopeptides present in LexA:EphB2 were also detected in full-length EphB2 (Figure 6a ), and two additional spots were detectable in the map of full-length EphB2. Thermolytic phosphopeptide maps of the LexA:EphB2 Y605F, Y611F and Y605/611F mutants were also generated (Figure 6c, d, e) . Each of these mutants displayed patterns of phosphorylation similar to the wild-type except for two phosphopeptides. Phosphopeptide c was not present in the Y605F mutant ( Figure 6c) ; phosphopeptide b was not present in the Y611F mutant ( Figure 6d) ; and neither peptide was present in the Y605/ 611F double mutant (Figure 6e ). Both tyrosine 605 and tyrosine 611 must, therefore, represent phosphorylation sites. However, the relative intensities of the signal for peptides b and c suggests that if equal amounts of each peptide are present, tyrosine 611 is a major autophosphorylation site and tyrosine 605 is a minor one. In addition, because several major phosphorylated peptides remained after both tyrosine 605 and tyrosine 611 were mutated to phenylalanine (Figure 6e ), these two tyrosines must not be the only autophosphorylation sites of EphB2.
Since our phosphopeptide maps veri®ed that the phosphorylation sites of the LexA:EphB2 fusion protein all re¯ect phosphorylation sites found in fulllength EphB2, the yeast two-hybrid system was chosen as a suitable method for identifying the binding sites of SH2 domains. To examine whether the dierent LexA:EphB2 fusion proteins bind to the SH2 domain of Src, the SH2 domain of chicken Src (`prey' protein) was fused to the VP16 transactivation domain in the yeast expression vector pVP16 (VP16:Src SH2). The wild-type LexA:EphB2 and VP16:Src SH2 plasmids were then co-transformed in the yeast L40 strain. Two reporter genes, the HIS3 gene and the lacZ gene, are under the control of the LexA promoter in the yeast L40 strain. Transcriptional activation triggered by the interaction of the LexA:EphB2 and VP16:Src SH2 fusion proteins was thus monitored by assessing growth in histidine free medium (THULL medium) and measuring b-galactosidase activity. Yeast colonies expressing both wild-type LexA:EphB2 and VP16:Src SH2 domain were visible on histidine free medium two days after transformation (Figure 7) , re¯ecting a high transcriptional activation of the HIS3 gene. In contrast, yeast colonies co-transformed with wild-type LexA:EphB2 and control VP16 plasmids, such as the VP16 fused to the insulin receptor substrate 1, were unable to grow on histidine free medium even after a week (not shown). Hence, the interaction between the cytoplasmic domain of wild-type EphB2 and the SH2 domain of Src appeared speci®c under yeast twohybrid system conditions.
The relative strength of the interaction between the various LexA:EphB2 fusion proteins and the Src SH2 domain, which is re¯ected by the level of activation of the lacZ reporter gene (Estojak et al., 1995) , was determined by the intensity of the blue color obtained in b-galactosidase ®lter assays (Figure 7a) . Binding of the LexA:EphB2 Y605F mutant to the Src SH2 domain appeared slightly decreased compared to wild-type LexA:EphB2. In contrast, binding of the Y611F mutant to the Src SH2 domain was very low, and the Y605/611F double mutant exhibited no detectable binding. Similar results were reached by assessing the growth of yeast on histidine free medium: the interaction between wild-type LexA:EphB2 or LexA:EphB2 Y605F with the Src-SH2 domain resulted in activation of the histidine reporter gene, which conferred the ability of yeast cotransformants to grow on histidine free plates, whereas no interaction between LexA:EphB2 Y611F and Src was detected by this assay (Figure 7c ).
To determine if the LexA:EphB2 Y611F mutant was properly folded and suciently active in yeast to create phosphotyrosine acceptor sites for SH2 domains other than Src, we tested the interaction between LexA:EphB2 Y611F and the carboxyterminal SH2 domain of phospholipase Cg (PLCg). Analysis by colorimetric staining in the b-galactosidase ®lter assay (Figure 7b ) and assay of the ability of yeast cotransformants to grow on histidine free medium (Figure 7d ) revealed that, besides the wildtype and LexA:EphB2 Y605F proteins, also the LexA:EphB2 Y611F protein interacted with the SH2 domain of PLCg (Figure 7b ). These results demonstrate that the inhibition of Src SH2 domain binding to LexA:EphB2 Y611F was not due to insucient overall autophosphorylation of EphB2, but rather to the mutation of a tyrosine (tyrosine 611) that is required for binding. Binding of the PLCg SH2 domain to LexA:EphB2 Y611F also suggests that in addition to tyrosine 611, other sites of tyrosine phosphorylation are present in EphB2 that are able to mediate binding of SH2 domain-containing proteins.
To verify that phosphorylation of tyrosine 611 of EphB2 is required for binding of the Src SH2 domain, a mutant of EphB2 was constructed in which lysine 662 was mutated to arginine. Lysine 662 corresponds to a conserved residue that participates in binding ATP and is required for catalytic activity of other receptor tyrosine kinases (Ullrich and Schlessinger, 1990) . When expressed in yeast, the LexA:EphB2 K662R mutant was present as similar levels as wild-type LexA:EphB2 (Figure 8a ). However, as expected, LexA:EphB2 K662R did not exhibit detectable autophosphorylation in a kinase assay (Figure 8b) . A b-galactosidase assay performed with yeast colonies expressing LexA:EphB2 K662F together with VP16:Src SH2 showed that the SH2 domain of Src does not interact with the cytoplasmic domain of kinase inactive EphB2, which is not phosphorylated on tyrosine. Therefore, phos- ATP, separated by 12% SDS ± PAGE, transferred to PVDF membrane, and exposed for autoradiography. By immunoblotting with anti-GST-EphB2 antibodies it was veri®ed that equal amounts of LexA:EphB2 were present in the immunoprecipitates in b (not shown). In c the interactions between wild-type or LexA:EphB2 K662R and the SH2 domain of Src fused to the transactivation domain, VP16, were tested by a b-galactosidase ®lter assay. The co-transformed yeast were streaked on UTL medium, grown for 2 days, then replica plated on nitrocellulose ®lters and assayed for b-galactosidase activity. The colorimetric reaction was stopped after 20 min phorylation of tyrosine 611 is required for binding of the SH2 domain of Src.
Taken together, our data demonstrate that tyrosine 611 is a major autophosphorylation site of EphB2 and that its mutation to phenylalanine strongly impairs binding of the Src SH2 domain. We therefore propose that upon EphB2 autophosphorylation, tyrosine 611 in the juxtamembrane domain is the principal binding site for Src.
Mutation of tyrosines 605 and 611 in the juxtamembrane region of EphB2 impairs kinase activity
As shown in Figures 5b and c , mutation of tyrosine residues 605 and 611 in the EphB2 juxtamembrane region resulted in impaired autophosphorylation of the LexA:EphB2 fusion proteins. To investigate more closely if mutations in the juxtamembrane region additionally aect the kinase activity of EphB2 towards exogenous target proteins, we measured the in vitro phosphorylation of a substrate by wild-type and mutated LexA:EphB2. We recently identi®ed the cytoplasmic domain of the neural cell adhesion molecule L1 fused to glutathione S-transferase (GST-L1) as an excellent substrate for EphB2 (Zisch et al., 1997) . Immunoprecipitated LexA:EphB2 fusion proteins were incubated with GST-L1 and [g 32 P]ATP. Autoradiography revealed that the mutant LexA:EphB2 fusion proteins did not phosphorylate GST-L1 as eciently as wild-type LexA:EphB2 (Figure 9 ).
Discussion
The changes in direction and motility of the neuron's growth cone presumably re¯ect the activation of signaling pathways that modulate, for example, the cytoskeletal architecture of neurons. Eph receptors and their ligands have been implicated in growth cone guidance by a repulsive mechanism that appears to involve disruption of the actin cytoskeleton Tessier-Lavigne, 1995; Meima et al., 1997a,b) . However, the downstream intracellular events beyond the initiation of signaling cascades through autophosphorylation (activation) of the Eph receptors, are only beginning to be elucidated. Here, we identify Src as a binding partner of EphB2. As a consequence of this interaction, Src kinase would become localized at sites were activated EphB2 is concentrated, namely axons and growth cones.
In cells in which EphB2 is phosphorylated on tyrosine, we observed reduced electrophoretic mobility and altered tyrosine phosphorylation of a substantial portion of the Src molecules. These are similar to the modi®cations of Src occurring upon activation of the PDGF receptor (Ralston and Bishop, 1985) , which reportedly re¯ect phosphorylation of residues in the amino terminus of Src and increased Src kinase activity (Gould and Hunter, 1988; Stover et al., 1996) . Interestingly, Src activity has been associated with changes in cytoskeletal organization (Thomas et al., 1995; Parsons and Parsons, 1997; Brunton et al., 1997) , such as those that might occur during the migration of cells (Hall et al., 1996; Boyer et al., 1997) and the retraction of neurites (Schindelholz et al., 1997) .
We have shown that tyrosine 611 in the EphB2 cytoplasmic domain is a major in vitro autophosphorylation site and the predominant binding site for Src. Because tyrosine 611 is located within a sequence motif that is conserved in all the receptors of the Eph family, signaling through Src is likely to be a common feature of the Eph receptors. Although it remains to be demonstrated that tyrosine 611 of EphB2 becomes phosphorylated upon ligand binding, we found that the SH2 domain of Src binds to in vivo phosphorylation sites of chicken EphB2, EphA3, and EphA4. The binding of Fyn to mouse EphA4 has also been recently reported (Ellis et al., 1996) . The binding site for Fyn includes tyrosine 602 in EphA4, which is the residue corresponding to tyrosine 611 in EphB2. Our data, however, suggest that in vivo phosphorylation of Eph receptors results in the preferential recruitment of Src, rather than Fyn or Yes, into the signaling pathways of these receptors. The SH2 domain of Src exhibited a binding preference for all three retinal Eph receptors tested; however, Yes also bound to EphA3 and EphB2, and Fyn also bound to EphA3. How the SH2 domains of Src family kinases discriminate between receptors is unknown, but it is possible that additional nonconserved residues, besides those in the immediate vicinity of the sequence motif identi®ed as the key site of interaction, are also necessary to provide the speci®city observed.
Our results also indicate that the SH2 domain of Src binds to EphB2 with high anity. Although only a small fraction of the EphB2 receptors are phosphorylated on tyrosine in embryonic day 13 chicken retina , and although EphB2 represents a minor portion of the proteins phosphorylated on tyrosine (unpublished data), binding of the Src SH2 domain to EphB2 is easily detected. The association between EphB2 and the SH2 domain of Src is very Tyrosines in the EphB2 juxtamembrane region are important for kinase activity. Kinase activities of wild-type and mutant LexA:EphB2 fusion proteins were determined by their ability to phosphorylate the cytoplasmic domain of the neural cell adhesion molecule L1 fused to GST (GST-L1) in in vitro kinase reactions. For the phosphorylation assay, GST-L1 was incubated with LexA:EphB2 immunoprecipitates for 20 min at 378C in the presence of [g 32 P]ATP. The immunoprecipitates were resolved by SDS ± PAGE and electrotransferred to a PVDF membrane, which was then exposed for autoradiography (a). The membrane shown in A was then probed with anti-GST antibody to verify the amounts of GST-L1 present in the kinase reactions (b) stable, since it withstands stringent detergent buer conditions (RIPA buer).
Interestingly, it is possible that tyrosine 611 of EphB2 also represents a binding site for other families of SH2 domain-containing proteins, which would compete with Src family kinases for binding and deliver dierent signals in the cell. During the preparation of this manuscript, we became aware of a study by Pawson and coworkers that demonstrates the association between mouse EphB2 and RasGAP (Holland et al., 1997) . Simultaneous substitution of both juxtamembrane tyrosines 604 and 610 in mouse EphB2 (corresponding to tyrosines 605 and 611 in chicken EphB2) with phenylalanine abolished ligandinduced phosphorylation of EphB2 in cultured cells and complex formation between RasGAP and EphB2. Moreover, RasGAP was shown to bind a diphosphopeptide encompassing tyrosines 604 and 610. It seems likely, therefore, that the stretch of amino acids in the juxtamembrane region of EphB2 that comprises tyrosines 605 and 611 represents a critical region that may mediate competing interactions of eector proteins. Indeed we found that tyrosine 605 of EphB2 is also phosphorylated, but apparently to a lesser extent than tyrosine 611.
Unlike previous studies, which have suggested that the juxtamembrane tyrosines 596 and 602 of EphA4 are the only autophosphorylation sites (Ellis et al., 1996) , our phosphopeptide mapping experiments revealed that other tyrosine residues, besides tyrosines 605 and 611, are autophosphorylation sites in EphB2 and are, therefore, likely to also be involved in signaling. Importantly, the double mutation of tyrosines 605 and 611 in the juxtamembrane domain to phenylalanine impaired the kinase activity of EphB2 causing decreased autophosphorylation at other sites as well. Since phosphorylation at sites in the juxtamembrane domain of other receptor tyrosine kinases modulates receptor kinase activity (Whiteley and Glaser, 1986; Davis, 1988; Feener et al., 1993; Mori et al., 1993; Gandino et al., 1994) , it is tempting to speculate that phosphorylation of tyrosines 605 and 611 of EphB2 and the corresponding tyrosines of other Eph receptors not only creates binding sites for SH2 domains, but also regulates kinase activity. Interestingly, mutation of tyrosines 579 and 581 in the juxtamembrane domain of the PDGF receptor to phenylalanine abolished the ligand-induced kinase activity of the receptor (Mori et al., 1993) .
Src, Yes, and Fyn have been shown to bind through their SH2 domains to the juxtamembrane region of other tyrosine kinases, such as the PDGF and CSF-1 receptors (Kypta et al., 1990; Courtneidge et al., 1993) . When Src binds to activated PDGF receptor, it becomes phosphorylated on tyrosine in the SH2 domain and there is a transient increase in Src kinase activity (Stover et al., 1996) . In a similar interaction between Src and EphB2, modulation of Src kinase activity may occur through phosphorylation of its SH2 domain by EphB2.
Src family kinases are essential for signaling by the PDGF, CSF-1, EGF, FGF and NGF receptors (Kremer et al., 1991; Mori et al., 1993; TwamleyStein et al., 1993a; Roche et al., 1995; Lombardo et al., 1995) . In ®broblasts, Src has been implicated not only in carrying out the mitogenic eects of PDGF (Twamley-Stein et al., 1993b) by activating a pathway that leads to increased Myc transcription , but also in organizing the cytoskeleton (Thomas et al., 1995) and mediating cell locomotion (Hall et al., 1996) . In epithelial cells, on the other hand, Src has been shown to mediate cell scattering and morphological changes, but not mitogenic eects (Warren et al., 1988; Rodier et al., 1995; Boyer et al., 1997) . Src also seems to be essential for neuronal dierentiation of PC12 cells following stimulation with FGF or NGF (Kremer et al., 1991) . Activation of Eph receptors does not cause cell proliferation in ®broblasts (Lhotak and Pawson, 1993; Brambilla et al., 1995) or neuronal differentiation in PC12 cells (our unpublished data). Rather than cell proliferation, regulation of growth cone motility and axon fasciculation is the likely outcome of the interaction between Eph receptors and their ligands in neurons Tessier-Lavigne et al., 1995) . Src may represent one of the functional links between Eph receptors and the downstream eector molecules that modulate the morphological changes necessary for growth cone outgrowth or retraction.
Materials and methods
Antibodies
Anity-puri®ed polyclonal antibodies to glutathione Stransferase (GST) (Soans et al., 1996) , phosphotyrosine (Pasquale, 1991) , b-galactosidase-EphB2 (Pasquale, 1991) , GST-EphB2 (Holash and Pasquale, 1995) , EphA3 and EphA4 (Soans et al., 1994) were generated as previously described. The mouse monoclonal antibody 327 speci®c for Src (Lipsich et al., 1983) was kindly provided by Dr Tony Hunter (The Salk Institute, California). For immunoblotting experiments, the anti-Src antibody was biotinylated using EZLink 2 sulfo-NHS-LC-biotin (Pierce).
Generation and puri®cation of GST fusion proteins
A GST fusion protein containing the entire cytoplasmic domain of a variant form of EphB2 with a 16 amino acid insertion in the juxtamembrane domain (Sajjadi and Pasquale, 1993) , was generated by PCR ampli®cation of EphB2 nucleotides 1729 ± 2057 (Pasquale, 1991) with the sense primer GGATCCAACAGAAGACGGGGC, containing a BamHI site (underlined), and the antisense primer ATGATGCTGGCTTCACTCAG. The PCR product was cloned in to the pCRII vector and sequenced. A EphB2 fragment, which was obtained by digestion at the introduced BamHI site and at an endogenous HindIII site at position 1957, was ligated together with a HindIII to EcoRI fragment of EphB2 comprising nucleotides 1958 to 3228 into the BamHI and EcoRI sites of the expression vector pGEX-2T. The SH2 domain of Src (Takeya and Hanafusa, 1983 ) was ampli®ed by PCR from an 11-day chicken embryonic retina cDNA library (Holash et al., 1997) with the sense primer GGCTGGATCCTGGTACTTTGGGAAGATCAC and the antisense primer GGAATTCCTGGGGCTTGGACGTGG-GGC. The SH2 domain of Yes (Zheng et al., 1989) was ampli®ed from a Yes lgt11 clone previously isolated (Pasquale and Singer, 1989 ) from a 10-day chicken embryo library (Clontech) using the sense primer AGCGG-GATCCTGGTACTTTGGTAAAATG and the antisense primer GGAATTCTTGTGGTTTCACCGTGGG. The SH2 domain of Fyn (Sudol et al., 1993) was ampli®ed from the retina library with the sense primer CGAATTCTTG-TGGGGTATTATTCGTAGC and the antisense primer AGCAGGATCCTGGTACTTCGGCAAACTTGG.
The sense primers contain a BamHI site (underlined) and the antisense primers contain an EcoRI site (underlined). The PCR products encoding the three SH2 domains were digested with BamHI and EcoRI, cloned in the expression vector pGEX-4T-1 (Pharmacia), and sequenced.
GST fusion proteins were expressed in E. coli XL1 Blue and puri®ed as previously described (Kaelin et al., 1992) . Brie¯y, bacterial cultures were pelleted and resuspended in 1/ 25 of the culture volume in Hyb 75 buer (20 mM HEPES, pH 7.7, 75 mM KCl, 0.1 mM EDTA, 2.5 mM MgCl 2 , 5 mM dithiothreitol (DTT), 0.05% Triton X-100). The bacterial suspensions were sonicated for 1.5 min, then clari®ed by centrifugation. GST proteins in the supernatants were puri®ed on glutathione-sepharose following the procedures recommended by the manufacturer (Pharmacia).
Binding assays with GST fusion proteins
For ®lter binding assays, the cytoplasmic domain of EphB2 fused to GST was puri®ed on 150 ml glutathione-sepharose in the presence of 400 mM sodium orthovanadate, 200 mM phenylarseneoxide, and subsequently phosphorylated in an in vitro kinase reaction with 20 mCi [g 32 P]ATP. After extensive washing with Hyb75 buer, the 32 P-labeled GST-EphB2 was eluted in 0.5 ml of 20 mM glutathione, 100 mM Tris, pH 7.5, 120 mM NaCl, 0.1% Triton X-100. Various dilutions of GST and GST fused to the SH2 domains of Src and Yes were spotted onto a nitrocellulose ®lter and stained with Ponceau S to verify protein amounts. The ®lter was then blocked and hybridized with 35 000 c.p.m./ml 32 P-labeled GST-EphB2 in blocking buer, as previously described (Kaelin et al., 1992) .
To examine the interaction between EphB2 expressed in B28 cells by transient transfection (Zisch et al., 1997) and the SH2 domain of Src, 15 ml of Src-SH2-agarose (2 mg/ml; Oncogene Science) or 30 mg of GST bound to 15 ml glutathione-sepharose were incubated with B28 cells solubilized in RIPA-buer (1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 10 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA) containing 400 mM sodium orthovanadate and 5 mM DTT. After overnight incubation at 48C, the beads were washed, and bound proteins were analysed by SDS ± PAGE and immunoblotting.
To examine the interaction between EphB2 from embryonic day 13 chicken retina and the SH2 domains of Src family kinases, retinas were harvested in ice cold PBS supplemented with 1 mM sodium orthovanadate as described (Zisch et al., 1997) . To enrich for the membrane proteins, retinas were homogenized in 1 M NaCl, 10 mM Tris, pH 7.5, 1 mM sodium orthovanadate. The insoluble protein fraction was collected by centrifugation and resuspended in RIPA buer supplemented with 1 mM sodium orthovanadate. Extracts were then sonicated for 10 s, further extracted for 30 min, and clari®ed by centrifugation. The supernatants were supplemented with 5 mM DTT and precleared by incubation with glutathione-sepharose for 100 min at 48C. Aliquots of the extracts were incubated overnight at 48C with glutathione-sepharose containing approximately 30 mg of bound GST fused to the SH2 domains of Src, Yes, or Fyn. After extensive washing, bound proteins were eluted and analysed by SDS ± PAGE and immunoblotting.
Immunoblotting
Proteins were separated on acrylamide gels, electrotransferred to polyvinyl di¯ouride membranes (PVDF) (Millipore) and stained with 0.2% Ponceau S. Membranes were blocked with either 3% BSA in Tris buered saline (TBS) (in case of subsequent probing for phosphotyrosine), or 3% non-fat milk in TBS. Incubations with primary antibodies were for 1 ± 3 h at room temperature and primary antibodies were used at 1 ± 3 mg/ml in blocking buer. Detection of the primary rabbit polyclonal antibodies was performed with protein A-peroxidase (Sigma) as secondary reagent and an enhanced chemiluminescence detection system (Amersham Life Science). Biotinylated mouse monoclonal anti-Src antibody was detected with an avidin-peroxidase conjugate (Sigma). In re-probing experiments, antibodies were stripped by a 30 min incubation at 508C with stripping buer (62.5 mM Tris, pH 7.5, 2% SDS, 100 mM mercaptoethanol). Membranes were then washed with TBS, blocked and probed again with antibodies as described above.
Immunoprecipitation
For immunoprecipitation experiments, 5 ml cultures of yeast were grown to an OD 600 of approximately 0.5, pelleted, and resuspended in 300 ml of yeast lysis buer (0.5 Triton X-100, 50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1 mM sodium orthovanadate, 1 mM phenylmethan sulfonyl¯uoride, 5 mg/ml leupeptin). The yeast cell suspensions were then vortexed in Eppendorf tubes in the presence of 300 ml of 425 ± 600 acid washed glassbeads (Sigma) eight times one min, with intermittent cooling on ice. The suspensions were then clari®ed by centrifugation. Immunoprecipitations were performed as previously described (Zisch et al., 1997) . Brie¯y, lysates were incubated with 10 mg of anti GST-EphB2 antibody, or non-immune rabbit IgG, bound to 15 ml of the immunoadsorbent Gammabind Plus Sepharose (Pharmacia) and the bound material was examined by SDS ± PAGE and immunoblotting.
To examine the interaction between EphB2 and Src in coprecipitation experiments, Cos cells were transiently transfected with EphB2 in pcDNA3, chicken Src in pcDNA3, or both, using the calcium phosphate method (Ausubel et al., 1997) . Cells were solubilized in 1% Brij 96 buer or RIPA buer, supplemented with 1 mM sodium orthovanadate, as previously described (Zisch et al., 1997) . Src was immunoprecipitated with speci®c antibodies and the presence of EphB2 associated with Src was assessed by immunoblotting with anti-phosphotyrosine antibodies. To examine the extent of Src phosphorylation on tyrosine, Src was immunoprecipitated with speci®c antibodies and the immunoprecipitates were immunoblotted with anti-phosphotyrosine antibodies. Alternatively, tyrosine-phosphorylated proteins were immunoprecipitated with anti-phosphotyrosine antibodies and the immunoprecipitates were immunoblotted with anti-Src antibodies.
For sequential immunoprecipitations, EphB2 bound to Src-SH2 agarose was eluted by boiling for 15 min in 100 ml of 3% SDS, 10 mM Tris, pH 7.6, 1 mM sodium orthovanadate (Zisch et al., 1995) . The eluted fraction was diluted with 1.2 ml of 1% Brij 96 buer and subjected to immunoprecipitation with anti GST-EphB2 antibody or non-immune IgG.
In vitro kinase assays
For kinase reactions, GST-EphB2 bound to glutathioneagarose or EphB2 immunoprecipitates were incubated with 10 mCi of [g 32 P]ATP in kinase buer (25 mM HEPES, pH 6.9, 3 mM MnCl 2 , 200 mM sodium orthovanadate) for 20 min at room temperature. The immunoprecipitates were then washed with lysis buer and analysed by SDS ± PAGE and autoradiography.
Two hybrid plasmids
The cytoplasmic domain of EphB2 was cloned into the yeast expression plasmid pBTM116 (`bait' plasmid) as follows: the sequence corresponding to amino acids 574 ± 995 of EphB2 was ampli®ed by PCR using the full length EphB2 cDNA (Sajjadi and Pasquale, 1993) as template and custom oligonucleotide primers. The sense primer, CGGGATCCGCAACAGAAGACGGGGGC, included a BamHI site (underlined) and the antisense primer, GACGTCGACTCAAACCTCCACAGACT, included a SalI site (underlined). The PCR product was digested with BamHI and SalI and ligated into BamHI and SalI digested pBTM116 plasmid. This resulted in the in frame fusion of EphB2 sequences to the upstream LexA DNAbinding domain. The sequence of the PCR-generated EphB2 cytoplasmic domain in pBTM116 was con®rmed by ABI PRISM 2 dye termination cycle sequencing (Perkin Elmer, Foster City, CA). Transformation of the yeast Saccharomyces cerevisiae strain L40 with the LexA:EphB2 plasmid resulted in the constitutive expression of the LexA:EphB2 fusion protein under the control of the S. cerevisiae alcohol dehydrogenase 1 (ADH1) promoter.
To fuse the chicken SH2 domain of Src to the VP16 transactivation domain, we used the chicken Src SH2 domain as template for PCR ampli®cation with oligonucleotide primers. The sense primer, TTGGATCCCCTGGTACTT-TGGGAAGATC, included a BamHI site (underlined) and the antisense primer, TCTATCTAGCGGCCGCTGGGG-CTTGGACGTGG, included a NotI site (underlined). The PCR product was digested with BamHI and NotI and ligated into BamHI and NotI digested pVP16 (`prey' plasmid). Transformation of the yeast L40 strain with the pVP16:Src-SH2 domain plasmid resulted in the constitutive expression of the VP16:Src-SH2 domain fusion protein under the control of the S. cerevisiae ADH1 promoter.
The C-terminal domain of PLCg (Suh et al., 1988) in the plasmid pVP16 was obtained from an E9.5-10.5 embryonic murine library in a two-hybrid screen using the cytoplasmic domain of EphA4 as`bait' (unpublished data).
Site-directed mutagenesis
To mutate tyrosines 605 and 611 in the cytoplasmic domain of EphB2 to phenylalanines, and lysine 662 to arginine, point mutations were introduced by sequential PCR steps (Ausubel et al., 1997) using LexA:EphB2 cDNA as template and overlapping primers encoding the mutations. To obtain the LexA:EphB2 Y605F mutant, the sense primer GAAGATTTTTATCGATCCATTT and the antisense primer GATCGATAAAAATCTTCATGGG (mutations underlined) were used together with the primers anking the EphB2 cytoplasmic region previously used to generate LexA:EphB2 (see`Two hybrid plasmids'). A 5' and a 3' overlapping PCR fragments were generated in two separate PCR reactions and then annealed and ampli®ed in a second PCR step with the external primers only. The PCR ®nal product was digested with BamHI and SalI and ligated into the BamHI and SalI digested pBTM116 vector. In a similar manner, tyrosine 611 of EphB2 was mutated to phenylalanine by using the overlapping mutagenic primers CGATCCATTTACCTTCGAAGATCCCAAT-GAGGC and GCCTCATTGGGATCTTCGAAGG-TAAATGGAT-CG (mutations underlined). This latter set of oligonucleotides was also used to mutate tyrosine 611 of LexA:EphB2 Y605F to phenylalanine, which yielded the plasmid LexA:EphB2 Y605/611F. To obtain double mutation of tyrosines 605 and 611 in LexA:EphB2, a ®rst fragment was generated by PCR using the 5'¯anking primer and oligonucleotide GCCTCATTGGGATCTTC-GAAGGTA-AATGGATCG (mutation underlined) and plasmid LexA:EphB2 Y605F as template. A second fragment was obtained by PCR with the 3'¯anking primer and oligonucleotide CGATCCATTTACCTTC-GAAGATCCC-AATGAGGC using the plasmid LexA:EphB2 as template. Both fragments were annealed and ampli®ed with the¯anking primers. The fragment was then digested with BamHI/SalI, recovered and ligated into BamHI/SalI digested pBTM116.
All LexA:EphB2 constructs were sequenced between the BamHI site and the HindIII to ensure that the expected mutation was present. To circumvent unwanted PCRintroduced mutations in the remaining sequence of LexA:EphB2 cytoplasmic domains, the LexA:EphB2 cytoplasmic domains, carrying the mutations Y605F or Y611F or Y605/611F were digested with BamHI and HindIII. These fragments were then subsequently ligated together with a HindIII to SalI fragment of wild-type LexA:EphB2 into the BamHI and SalI sites of pBTM116 plasmid to yield LexA:EphB2 Y605F, LexA:EphB2 Y611F and LexA:EphB2 Y605/611F. Lysine 662 of EphB2 was similarly mutated by using the overlapping mutagenic primers TTTGTGGCCAT-CAGGACCCTGAAG and CTTCAGGGTCCTGATGGCC-ACAAA. A mutated fragment was sequenced, digested with Bsp 106I and DraIII, and cloned into the wild-type LexA:EphB2 cDNA digested with the same enzymes.
Assays for interactions using the yeast two-hybrid system
The S. cerevisiae strain L40, which contains the reporter genes His3 and lacZ under the control of LexA promoter, has the following genotype: MATa his3 trp1 leu 2 adfe2 LYS2::(lexAop) 4 -HIS3 URA3::(lexAop) 8 -lacZ. (Vojtek and Hollenberg, 1995) . Yeast transformants were grown in synthetic medium consisting of yeast nitrogen base without amino acids (Difco Laboratories), 20 g/l glucose, and appropriate amino acid supplement mixtures (Bio 101, Inc.). These supplement mixtures lacked either tryptophan (-Trp medium), or uracil, tryptophan and leucine (UTL medium), or tryptophan, histidine, uracil, lysine and leucine (THULL medium). Cotransformations of LexA:EphB2 expression plasmids together with VP16 expression plasmids were performed sequentially, using the lithium acetate method (Hill et al., 1991) . Because the LexA plasmid conferred the ability to grow in the absence of tryptophan and the VP16 plasmid conferred the ability to grow in the absence of leucine, co-transformants were selected on UTL medium. Interactions between LexA:EphB2 and VP16: fusion proteins were detected based on the ability of the co-transformants to grow on THULL medium and on b-galactosidase activity. We observed a weak non-speci®c activation of the His3 reporter gene by the LexA:EphB2 protein (self activation), which was completely suppressed by the addition of 15 mM 3-amino-1,2,4-triazole into the THULL medium.
For the b-galactosidase ®lter assays, L40 yeast transformants were streaked on UTL plates, grown for 2 days, then replica plated onto Hybond-C nitrocellulose ®lters (Amersham Life Science). For the colorimetric assay, membranes were incubated with 0.4 mg/ml 5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-gal) in Z-buer (60 mM Na 2 HPO 4 , 40 mM NaH 2 PO 4 , 10 mM KCl, 1 mM MgSO 4 , pH 7.0) for 20 min at 308C.
Phosphopeptide mapping
Immunoprecipitated full length EphB2 and wild-type and mutant LexA:EphB2 fusion proteins were subjected to in vitro kinase reactions in the presence of [g 32 P]ATP and separated by SDS ± PAGE. Full-length EphB2 was obtained from lysates of 293 human kidney cells transiently transfected with the cDNA of EphB2 by calcium phosphate precipitation. After elution from gel slices, the phosphorylated forms of EphB2 were digested with thermolysin (Calbiochem) as described previously (Boyle et al., 1991) . Two thousand c.p.m. of each digest were resolved in two dimensions on 100 mm620 cm620 cm thin-layer cellulose plates (EM Science) by electrophoresis followed by ascending chromatography. Electrophoresis was at pH 1.9 in 50 : 156 : 1794 :: 88% formic acid:glacial acetic acid:water for 40 min at 1000 V on a Hunter Thin Layer Electrophoresis System #HTLE-7000 (CBS Scienti®c). Ascending chromatography was in 750 : 500 : 150 : 600::n-butanol:pyridine:glacial acetic acid:water. The cellulose plates were exposed to X-ray ®lm for 4 days at 7708C with an intensifying screen.
